Joshua M Eizen insider trades
Open-market stock purchases and sales by Joshua M Eizen, See Remarks at AN2 Therapeutics, Inc, from SEC Form 4 filings since Oct 14, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $196K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $717K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $360K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $1.6M |
| Feb 20, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
| Feb 20, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
| Jan 6, 2026 | ANTX AN2 Therapeutics, Inc | Sold | $7K |
| Jan 5, 2026 | ANTX AN2 Therapeutics, Inc | Sold | $17.9K |
| Nov 4, 2025 | ANTX AN2 Therapeutics, Inc | Sold | $3.2K |
Companies traded
- ANTX AN2 Therapeutics, Inc: 4 sales, last Mar 19, 2026